Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

170
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
170
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

197
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
197
Confidence Coefficient01:24

Confidence Coefficient

7.6K
The confidence coefficient is also known as the confidence level or degree of confidence. It is the percent expression for the probability, 1-α, that the confidence interval contains the true population parameter assuming that the confidence interval is obtained after sufficient unbiased sampling; for example, if the CL = 90%, then in 90 out of 100 samples the interval estimate will enclose the true population parameter. Here α is the area under the curve, distributed equally under...
7.6K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

507
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
507
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

10.6K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
10.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

How to benchmark medical AI agents.

PLoS medicine·2026
Same author

Causal inference and digital twins: a roadmap for the future of clinical trials.

NPJ digital medicine·2026
Same author

Translation readiness of model-based synthetic tabular data in healthcare: a systematic review and governance audit.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

SynthCraft: An AI partner for synthetic data generation to support data access and augmentation in healthcare.

PLOS digital health·2026
Same author

Retrieval Augmented Thought Process for Private Data Handling in Healthcare.

IEEE journal of biomedical and health informatics·2025
Same author

Redefining digital health interfaces with large language models.

Frontiers in artificial intelligence·2025

相关实验视频

Updated: Jul 4, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.3K

线性解混得分方法:通过密集的未观察到混得分 DAG.

Alexis Bellot, Mihaela van der Schaar

    IEEE transactions on neural networks and learning systems
    |January 29, 2024
    PubMed
    概括

    这项研究引入了一种新的方法,可以从观测数据中发现因果关系,即使没有测量的混. 该方法利用独立机制的原则来确定复杂系统中真正的因果关系.

    科学领域:

    • 因果推理因果推理
    • 机器学习 机器学习
    • 统计建模 统计建模

    背景情况:

    • 没有测量的混对从观测数据中发现因果关系构成了重大挑战.
    • 基于约束的方法在未观察到的变量广泛影响观察到的变量时遇到困难,导致无法识别的因果关系.
    • 现有的方法在高维环境中经常失败,并且存在广泛的未观察到的混.

    研究的目的:

    • 开发一种方法来发现在存在未测量的混时的因果关系.
    • 利用独立机制的原则来分离假效应和因果关系.
    • 提出一个可扩展的算法,用于复杂系统的因果发现.

    主要方法:

    • 利用独立机制的原则来识别未观察到的混杂的统计足迹.
    • 应用稀疏线性高斯定向非循环图 (DAG) 模型用于因果结构恢复.
    • 开发一个基于得分的调整因果发现算法,与通用解决方案兼容.

    主要成果:

    • 根据独立机制的原则,证明未观察到的混会留下可检测的统计足迹.
    • 表明,一个稀疏的线性高斯式DAG可以从观测数据中大致恢复.
    • 拟议的算法可扩展到高维问题,并且对模型假设的偏差具有稳定性.

    更多相关视频

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.7K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.1K

    相关实验视频

    Last Updated: Jul 4, 2025

    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
    07:11

    Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

    Published on: November 10, 2023

    2.3K
    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.7K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.1K

    结论:

    • 通过利用独立机制原则,即使存在广泛的未测量混,因果发现也是可行的.
    • 开发的算法提供了一个可扩展和强大的解决方案,用于识别复杂的观测数据集中的因果结构.
    • 该方法显示了扩展到非线性结构模型的潜力,扩大了其适用性.